Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCyanconnode Share News (CYAN)

Share Price Information for Cyanconnode (CYAN)

Share Price is delayed by 15 minutes
Get Live Data
8.05    0.00 (0.00%)
Bid:
7.90
Ask:
8.20
Spread: 0.30 (3.797%)
Market Cap: £28.34m
CYAN Live PriceLast checked at - London Stock Exchange

Intraday Cyanconnode Share Chart

Daly buys at BAT

Fri, 01st Oct 2010 16:31
British American Tobacco's chief operating officer John Daly has invested nearly £511,000 in shares in the tobacco company. He has bought 21,200 shares at 2408.57p each and that takes his beneficial stake to 52,417 shares. Daly joined BAT as a result of its merger with Rothmans in 1999. He was appointed as chief operating officer of the group in September at the same time that Nicandro Durante took on the role of chief executive designate. Durante takes over as chief executive next February. Daly was previously regional director for Asia Pacific. In July, BAT said that it expects another year of good growth in both earnings and dividends. Pre-tax profit rose to £2,279m in the six months to 30 June, up from £2,123m in the first half of 2009. The tobacco firm increased its interim dividend from 27.9p a share to 33.2p a share.Top Director BuysBritish American Tobacco (BATS) Director name: Mr John DalyAmount purchased: 21,200 @ 2,408.57p Value: £510,617PSG Solutions (PGS) Director name: Mr Bernard Cavan ConnorAmount purchased: 300,000 @ 24.00p Value: £72,000GlaxoSmithKline (GSK) Director name: Dr Dr Dan PodolskyAmount purchased: 2,078 @ 1,265.19p Value: £26,291GlaxoSmithKline (GSK) Director name: Sir Christopher GentAmount purchased: 2,685 @ 1,257.00p Value: £33,750Ascent Resources (AST) Director name: Mr Jeremy EngAmount purchased: 699,815 @ 4.38p Value: £30,652GlaxoSmithKline (GSK) Director name: Mr Lawrence CulpAmount purchased: 1,539 @ 1,265.19p Value: £19,471Cyan (CYAN) Director name: Dr John ReadAmount purchased: 3,088,221 @ 0.90p Value: £27,794Cyan (CYAN) Director name: Mr Simon Smith Amount purchased: 2,777,778 @ 0.90p Value: £25,000GlaxoSmithKline (GSK) Director name: Sir Sir Crispin H L DavisAmount purchased: 1,889 @ 1,257.00p Value: £23,745Unilever (ULVR) Director name: Ms Ann M FudgeAmount purchased: 700 @ 1,849.80p Value: £12,949Top Director SellsCentamin Egypt (CEY) Director name: Mr Stuart BottomleyAmount sold: 200,000 @ 179.78p Value: £359,560Centamin Egypt (CEY) Director name: Mr Stuart BottomleyAmount sold: 200,000 @ 178.26p Value: £356,520BrainJuicer Group (BJU) Director name: Mr James GeddesAmount sold: 125,000 @ 200.00p Value: £250,000Centamin Egypt (CEY) Director name: Mr Stuart BottomleyAmount sold: 100,000 @ 177.91p Value: £177,910Red Rock Resources (RRR) Director name: Mr Andrew Ronald McMillan BellAmount sold: 1,000,000 @ 6.09p Value: £60,900Oxford Instruments (OXIG) Director name: Mr Charles HolroydAmount sold: 6,016 @ 500.45p Value: £30,107

Related News

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
1 day ago

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial

* GSK partner Hansoh reports first late-stage data ​for experimental ⁠lung cancer drug

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
1 day ago

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial

(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...

GSK hails 'milestone' drug trial results in China
1 day ago

GSK hails 'milestone' drug trial results in China

(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...

Cyanconnode News

IN BRIEF: Esyasoft deadline to make CyanConnode bid extended
23 Jun 2026

IN BRIEF: Esyasoft deadline to make CyanConnode bid extended

CyanConnode Holdings PLC - Cambridge, England-based developer of narrowband radio frequency mesh networks - Put up or shut up deadline for possible bi...

TRADING UPDATES: Manolete expects improved profitability and growth
24 Apr 2026

TRADING UPDATES: Manolete expects improved profitability and growth

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Friday and not separately reported by Alli...

CyanConnode expects revenue to rise to over £20m
24 Apr 2026

CyanConnode expects revenue to rise to over £20m

(Sharecast News) - CyanConnode said in an update on Friday that it expected annual revenue to rise to more than £20m, helped by the start of inst...

EARNINGS AND TRADING: Atome up as flags fertiliser disruption from war
31 Mar 2026

EARNINGS AND TRADING: Atome up as flags fertiliser disruption from war

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...

CyanConnode extends 'PUSU' deadline after revised offer from Esyasoft
3 Mar 2026

CyanConnode extends 'PUSU' deadline after revised offer from Esyasoft

(Sharecast News) - AIM-listed smart metering specialist CyanConnode said on Tuesday that it has requested and been granted an extension to the 'put up...

CyanConnode says minded to accept revised buyout proposal by Esyasoft
3 Mar 2026

CyanConnode says minded to accept revised buyout proposal by Esyasoft

(Alliance News) - CyanConnode Holdings PLC on Tuesday said it received an additional non-binding proposal from International Holding Co PJSC subsidiar...

AIM WINNERS & LOSERS: CyanConnode minded to approve new Esyasoft bid
3 Mar 2026

AIM WINNERS & LOSERS: CyanConnode minded to approve new Esyasoft bid

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.

LONDON MARKET OPEN: FTSE 100 stays down as conflict keeps airlines red
3 Mar 2026

LONDON MARKET OPEN: FTSE 100 stays down as conflict keeps airlines red

(Alliance News) - Stock prices in London opened firmly in the red on Tuesday in London, following the release of UK grocery data and ahead of the UK c...